Sanofi, seeking control of key drug, to buy Principia for $3.7B

[cafead]

via Sanofi on Monday said it will pay $3.68 billion to acquire partner Principia Biopharma in a deal that gives the French drugmaker full control over a promising experimental medicine for multiple sclerosis.

article source